The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has announced awards to establish four Cooperative Research Centers (CRCs) focused on developing vaccines to prevent sexually transmitted infections. The grants, totaling $41.6 million over five years, will support collaborative, multidisciplinary research on the bacteria that cause syphilis, gonorrhea and chlamydia. Each center will conduct at least three research projects organized on a common theme. One center will study syphilis, two will study gonorrhea, and the fourth center will be focused on chlamydia. At the end of the program, each center is expected to identify at least one candidate vaccine ready for testing in clinical trials.
Learn more about this initiative.